Docetaxel (D) plus gemcitabine (G) compared with G in elderly patients with advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized phase III Hellenic Oncology Research Group trial.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 7605-7605 ◽  
Author(s):  
A. Karampeazis ◽  
L. Vamvakas ◽  
A. G. Pallis ◽  
C. Christophyllakis ◽  
N. K. Kentepozidis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Research Group ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Oncology Research ◽  
Group Trial

Docetaxel Vs. Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: A Hellenic Oncology Research Group Randomized Phase III Study

2011 ◽  
Vol 12 (3) ◽  
pp. 155-160 ◽  
Author(s):  
Athanasios Karampeazis ◽  
Lambros Vamvakas ◽  
Athina Agelidou ◽  
Nikolaos Kentepozidis ◽  
Kyriakos Chainis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Research Group ◽  
Small Cell ◽  
Phase Iii ◽  
Small Cell Lung ◽  
Oncology Research ◽  
Phase Iii Study

Phase I/II trial of gemcitabine plus oral TS-1 in elderly patients with advanced non-small cell lung cancer: Thoracic oncology research group study 0502

Lung Cancer ◽  
2010 ◽  
Vol 69 (2) ◽  
pp. 213-217 ◽  
Author(s):  
Takashi Seto ◽  
Takeharu Yamanaka ◽  
Izumi Wasada ◽  
Nobuhiko Seki ◽  
Hiroaki Okamoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Research Group ◽  
Small Cell ◽  
Small Cell Lung ◽  
Oncology Research
Sign in / Sign up

Export Citation Format

Share Document